Lowa Zephyr Mk 2 GTX

Archive for the ‘Medical’ Category

Special Operations Forces Tackle Unseen Threat of Blast Exposure

Tuesday, September 8th, 2026

The U.S. special operations forces community is actively tackling the invisible threat of repeated blast overpressure to protect warfighters’ brain health without compromising combat readiness.

This is important since, in just six months of initial entry training, a SOF soldier will fire thousands of small arms rounds, employ hundreds of flash-bang devices, and conduct dozens of explosive breaches. For these operators, low-level blast exposure of less than four pounds per square inch is not a rare incident, but rather a daily, unavoidable reality of their training and operational environments. 

Managing this risk factor presents a massive challenge. The scientific community suspects that cumulative, repeated blasts could cause long-term cognitive effects, yet there are currently no validated thresholds to guide medical decisions or return-to-duty timelines.  

Simply tracking the blasts is a logistical hurdle because current sensors are often bulky, competing for precious space on an operator’s mission-essential gear. Furthermore, vendor data rarely synchronizes smoothly with standard military systems, and there is little agreement on how peak pressure and incident pressure meaningfully accumulate. 

“More importantly, current sensors only measure the blast wave itself, leaving a critical human gap with no event-linked cognitive, physiological or biomarker data for the operator standing in its path,” said Army Sgt. Maj. Chris McNamara, 3rd Operations Support Group human weapon system director. 

To bridge these scientific and operational gaps, the SOF community launched aggressive, data-driven initiatives like the Elite Force Pilot Team. 

“This specialized task force is evaluating how to implement high-fidelity monitoring during high-risk training and operations,” McNamara said. “Their goal is to ultimately standardize how leaders make risk and readiness decisions.”

The objectives of the pilot team are to mitigate effects of blast overpressure by monitoring high-risk training and operations. They have used lessons learned to improve return-to-duty and return-to-shoot protocols and correlate blast overpressure to clinical outcomes by using evidence-based biomarkers. 

McNamara highlighted the operational reality of these efforts, noting that a delicate balance exists between collecting timely data and not disrupting the tempo of training. He emphasized the essential need to identify accurate and nonintrusive methods for collecting data on blast exposure, cognitive performance and biomarkers.

“As the scientific community strives to find clarity in exposure measurement, leaders at all levels must simultaneously be equipped with relevant and effective risk-mitigation tools,” said Kathy Lee, director of warfighter brain health policy at the Office of the Assistant Secretary of War for Health Affairs.

Instead of waiting for universal medical standards to be finalized, SOF leaders are already implementing physical changes to training and equipment. One innovation is the multiuse charge housings for enhanced target effect, a flexible charge housing designed to optimize breaching operations while safeguarding service members.

Made of nontoxic, inert materials, the system is dual purposed for sheet explosives and detonation cords. By using advanced 3D computer modeling and wave-shaping design techniques, the housing focuses blast energy toward the target, allowing for a lower net explosive weight. This optimization delivers identical target-defeat capabilities while reducing hazardous blast overpressure on the warfighter by 25-60%.

The system is highly intuitive, significantly reduces charge preparation, builds time to maximize training efficiency and is currently being positioned for expanded military distribution.

“Our priority is to field technology that treats the operator as our premier weapon system,” said Chris Wilson, division lead for human weapon system at the U.S. Special Operations Command’s Science and Technology Directorate. “Innovations like [the housing] prove we don’t have to choose between lethality and safety. By using advanced engineering to shape the blast physics, we are actively lowering the physical toll on the human weapon system while keeping our operators sharp, lethal and in the fight longer.”

For SOF members, the firing ranges and facilities are being redesigned based on advanced modeling of blast waves. New construction materials are also being used that absorb shockwaves.

Operators are also seeing improvements in their standard gear. This includes the increased use of updated weapon suppressors, heavy weapon simulators and strict helmet policies.

Researchers are even using biometric instrumented head forms to measure exactly what happens inside a helmet during a blast, leading to improved helmet padding systems. For industrial hygiene monitoring, new hard-copy and mobile applications are being developed to streamline the recording of blast overpressure data directly in the field.

Ultimately, the overarching warfighter requirement remains clear: a low-burden sensor with integrated power and interoperable data that clinicians can actually use to monitor health.

By taking decisive action today, U.S. Special Operations Command is taking proactive steps to improve brain health, detect early warning signs and implement preventive measures to extend operational longevity, enhance mission readiness and ensure the long-term health of SOF warfighters.

By Derik Crotts, Office of the Assistant Secretary of War for Health Affairs

Air Force Global Strike Command Directs Stop Use of AN/PRM-10 Test Oscillator Set

Sunday, August 30th, 2026

BARKSDALE AIR FORCE BASE, La. —  

Air Force Global Stike Command has directed units within the command to stop use of the AN/PRM-10 test oscillator set, a signal generator used to examine intercontinental ballistic missile (ICBM)communications systems.

This order stems from a notification AFGSC and 20th Air Force received in August that an Airman assigned to F.E. Warren AFB discovered and was exposed to residue on a component of an AN/PRM-10 kit while performing a routine inspection. The Airman reported the issue, received medical attention, and was returned to duty with no adverse effects.

Subsequent tests on the residue confirmed the presence of polychlorinated biphenyls (PCBs), a substance commonly used in electrical devices during the time that equipment was developed to maintain the Minuteman III ICBM system.

Upon notification confirming the presence of PCBs in one AN/PRM-10 unit at F.E. Warren AFB, 20th AF directed a one-time inspection (OTI) to assess all AN/PRM-10 kits. Officials also directed updated safety warnings, precautions, and mandatory personal protective equipment requirements where legacy testers remained in use.

The OTI-directed review was completed within three days of issuance and covered the entire inventory of AN/PRM-10 kits across the command. Inspections found potential residue on six of eight AN/PRM-10 systems. Samples have been collected and are being sent for testing.

Upon receiving the OTI findings indicating the presence of potential residue on additional AN/PRM-10 kits, and as a precautionary measure while sample test results are pending, units in 20th AF are immediately stopping use of the AN/PRM-10 and transitioning from the AN/PRM-10 to a modern, PCB-free replacement tester.

“Twentieth Air Force takes the responsibility to protect our Airmen very seriously,” said Maj. Gen. Colin Connor, 20th AF commander. “As our Airmen are our greatest asset, their safety and health are my top priority.”

In addition to these measures, AFGSC and 20th AF officials are working closely with the Minuteman III systems program office to appropriately dispose of existing AN/PRM-10 kits and identify any other pieces of test equipment that may contain PCBs. 

There are no mission impacts as a result of these actions, and U.S. ICBM forces remain safe, secure, and effective to protect the U.S. homeland.

“We remain vigilant for issues like these and will continue to aggressively and immediately take the appropriate actions,” added Gen. S.L. Davis, commander of AFGSC.

This effort is the latest in a series of initiatives Air Force officials have directed, following the launch of the Missile Community Cancer Study in 2023, to review the Minuteman III system and its associated equipment to ensure a safe, hazard-free working environment for America’s ICBM force.

For more information on the Missile Community Cancer Study, please follow this link: www.airforcemedicine.af.mil/Resources/Missile-Community-Cancer-Study.

By Air Force Global Strike Command Public Affairs

See CTOMS at NTOA

Friday, August 28th, 2026

CTOMS, an industry leader in tactical medical training, equipment, rope access and medical solutions, will be exhibiting at the National Tactical Officers Association (NTOA) Law enforcement operations and Trade show, taking place from 29-30 August 2026 at the Gaylord Convention Center in Nashville, TN, USA.

Visitors to the CTOMS booth 521 will have a chance to go through medical equipment carriage and organization, new equipment developed by CTOMS and how CTOMS training pathways can enhance your medical readiness in your organization.

Discover how CTOMS can enhance your readiness. See you at booth 521.

New FDA Clearance Gives PTSD Patients More Precise, Effective Treatment Options

Sunday, August 23rd, 2026

Precision brain therapy uses new technology to target post-traumatic stress disorder at the source

HOUSTON, TexasApproximately 17.5 veterans die by suicide every day in the United States, and 7% of veterans are diagnosed each year with post-traumatic stress disorder (PTSD). Against that backdrop, Texas A&M Health researchers are helping to advance a more personalized approach to treating the disorder.

New technology developed by Wave Neuroscience, a California-based company, in collaboration with the research team of Kenneth S. Ramos, MD, PhD, with the Texas A&M Health Institute of Biosciences and Technology, has recently received FDA clearance for a system that maps and treats the specific parts of the brain impacted by PTSD. While the results are being processed for public dissemination, the findings have demonstrated promising results to revolutionize PTSD treatment options.

PTSD is a mental health condition that can develop after exposure to an event beyond average stressors, like combat, accidents, natural disasters or other forms of violence. About 6% of people will develop PTSD symptoms in their lifetimes, with women and veterans experiencing much higher rates.

Since PTSD became an official diagnosis in 1980, the most common treatments have been talk therapy and serotonin reuptake inhibitor (SSRI) medications, such as sertraline and fluoxetine. But statistics show that those treatments don’t work for everyone.

2020 study reviewing medications for PTSD found that while some patients improved, many did not. Patients’ self-reported symptoms improved by 6.8 to 10.1 points, and only up to 10.9% achieved remission.

The Wave Neuroscience clinical trial revealed much more promising preliminary results, according to the company’s chief medical officer Erik Won, DO.

“In comparison to that study, our FDA trial reported a 52% reduction in symptoms, so more than a four-fold increase in efficacy,” Won said. “And more importantly, we saw 68% remission in our clinical trial. So, it’s really a quantum change, an inflection point in what we can offer to patients. From a clinical care perspective, that’s really meaningful.”

Making it personal

The treatment uses Magnetic e-Resonance Therapy (MeRT), a technology created by Wave Neuroscience that combines an electroencephalogram (EEG) with transcranial magnetic stimulation. The EEG records electrical activity of the brain, while TMS—which is already used to treat other mental health conditions—uses magnetic pulses through a coil placed on the scalp.

“Transcranial magnetic stimulation, or TMS, was previously FDA cleared for treatment-resistant depression,” Won said. “By adding an augmented AI derived multivariate algorithm, we were able to personalize protocols that received FDA clearance for post-traumatic stress disorder, which should open up market access to about 13 million people who may be struggling with PTSD.”

That personalization is at the heart of MeRT.

Ramos, a physician-scientist with decades of experience in precision medicine, focuses on treatment tailored to the specific person and ailment rather than a “one-size-fits-all” approach.

“Most clinical interventions for the treatment of PTSD do not work very well,” Ramos said. “So, this is a huge area where identifying interventions that could hopefully add quality of life to the people impacted by this disorder would be tremendously impactful.”

As a leading researcher in precision medicine, Ramos was the obvious choice for Wave Neuroscience to bring into their study, said Fred Walke, chief executive officer at the company.

TMS is typically done generically, Ramos explained, but MeRT takes it one step further by customizing it to the person being treated.

Each of us is 99.9% the same, but the 0.1% difference among us dramatically changes the picture. By tailoring the treatment to the individual, the researchers were able to work with that person’s brain specifically and demonstrate significant decreases in severity of PTSD symptoms.

Ramos compared the two treatments to fixing a leaky roof: TMS, he said, is like putting a tarp over the leak to address the symptoms, while MeRT is more targeted, akin to replacing the broken shingles and addressing the problem at its source.

Breaking the mold

The path to FDA clearance began in 2024, when MeRT received the FDA breakthrough design designation, said Rick Silva, PhD, executive director of clinical trials at the Institute of Biosciences and Technology.

This designation provides an expedited pathway for FDA review. Strict scientific and medical guidelines still must be met, but the designation can reduce some of the administrative tasks that can delay getting treatments to patients.

Reaching the final stages of FDA clearance is a time-consuming and rigorous task, but for those involved, it’s all worth it.

This project, Silva said, was especially gratifying because it began during the COVID-19 pandemic and moved very quickly for an FDA clearance. While medical device clinical trials typically take around a decade to complete and gain FDA clearance, this was done in just over two years, he said.

The rigor it takes to succeed in this space reflects the expertise and talent of the Wave Neuroscience team, and it could not have been done without them, he added.

“I’ve been involved in probably close to 1,000 projects in academic medical centers over the years at varying degrees of depth and detail,” Silva said. “Patients are why I do what I do. It’s hard, and the failure rate is high, and it’s a lot of work. But when you get to a point where something is going to benefit patients, it’s very professionally gratifying and personally gratifying in many ways as well.”

For Israel Liberzon, MD, distinguished professor in psychiatry and behavioral sciences at the Texas A&M Naresh K. Vashisht College of Medicine, the clearance represents an important addition to the PTSD treatment landscape.

Liberzon served as the lead psychiatrist and PTSD expert for the study. He said once this treatment gets to patients, it will be the only non-medication treatment option for PTSD cleared by the FDA.

“Right now, the FDA has approved only two medications for PTSD,” Liberzon said. “It doesn’t mean that only two of them are used, but both are SSRIs. This is the first time that in addition to the medication, we have a non-medication option. There is psychotherapy that people use for PTSD, but psychotherapies require a lot of effort. People must participate actively, and many drop out because it’s too anxiety provoking. So now we have a unique alternative.”

The MeRT clinical trial involved five sessions per week over five to six weeks. The beneficial effects appear to be long-lasting beyond the termination of treatment.

“People living with PTSD have been left with trial-and-error treatment, medications and their side effects, and limited outcomes—even when treated by the most dedicated and experienced physicians,” Won said. “Wave’s FDA clearance signals a fundamentally different future: one in which PTSD can be objectively evaluated, precisely treated and meaningfully healed.”

The technology could eventually have applications beyond PTSD, Won said, including depression, anxiety and other conditions.

Hope on the horizon

For Leslie S. Prichep, PhD, chief scientific officer of Wave Neuroscience, the clearance signals a new era for mental healthcare.

“The FDA clearance of the MeRT System reflects decades of scientific research using electrophysiological biomarkers in identifying abnormal brain activity profiles and guiding personalized intervention strategies,” Prichep said. “We believe this represents an important advancement toward a more objective, data-informed model of mental healthcare.”

Walke said this alternative provides hope to those struggling with PTSD and their loved ones. He also hopes the more individualized approach will help reduce the stigma around mental health, as treatment becomes like putting a cast on a broken bone.

“One of the goals of the company is to create a platform for mental healthcare that uses objective imagery to help patients understand why they’re experiencing life the way that they are,” Walke said. “That insight, compounded with proven technologies, promises incredibly high efficacy when personalized.”

Alongside Texas A&M Health, Wave Neuroscience is working with key stakeholders to broaden access to the treatment and ensure it is affordable for patients through insurance coverage.

“Our hope is that this research and technology can be a catalyst for more widespread development and innovation of more effective, personalized and precision-guided treatments,” Won said. “This is proof positive that population-scale personalized medicine is not just an aspirational goal but is an achievable reality today.”

The MeRT team brings together decades of expertise spanning disciplines and technology, all with the goal of reducing suffering for people living with PTSD. FDA clearance brings them one step closer to that goal.

“Texas A&M has a very rich history of military and veteran priorities,” Ramos said. “It’s a no-brainer that Texas A&M faculty would be interested in and supportive of an initiative that hopefully would bring positive solutions to a big problem. And anything we could do to help alleviate that problem is going to go a long way towards making a difference in the individual’s life as well as the people who are close to them. I feel very fortunate that we at Texas A&M were meaningfully involved in this project.”

By LASHA MARKHAM for VITAL RECORD

Bundeswehr Orders Further Mobile Rescue Stations from Rheinmetall – Order Worth Over € 500 Million

Tuesday, August 18th, 2026

Rheinmetall will supply further mobile rescue stations to the Bundeswehr. As an extension of a previous order, the armed forces are set to receive a total of 149 additional protected and unprotected systems, with a gross value of over €500 million. This call-off under a framework contract awarded at the end of 2024 is the largest order to date that the contractor, Rheinmetall Project Solutions GmbH, has ever received. Production of the rescue stations is due to begin in the first quarter of 2027.
With the order booked in July 2026, the total number of rescue stations rises to 165 systems, with a gross value of over € 600 million. In December 2024, the Federal Office of Bundeswehr Equipment, Information Technology and In-Service Support (BAAINBw) had commissioned Rheinmetall to supply up to 137 rescue stations to the Bundeswehr. At that time, ten ballistically protected and six unprotected systems were ordered. 

Call-offs for further armoured and unarmoured systems are included as an option in the contract. Training for the relevant personnel will also be provided.

The rescue stations are part of the Modular Medical Facilities system. Within the Bundeswehr’s medical service, these highly mobile rescue stations ensure that the troops receive initial emergency medical care. If required, four soldiers can set up and dismantle the systems within a very short time. This incorporates a lesson learnt from the war in the Ukraine, namely that highly mobile systems are necessary for medical support.

Each rescue station comprises two containers that can be operated together or separately. Each container is fitted with a generator and air conditioning, and can operate independently for several days. Should one generator fail, the entire system can continue to operate using the generator from a single container.

The system features a fully equipped emergency treatment station, as well as four additional treatment stations. All the medical equipment is mounted on Airliner rails and can be configured according to the user’s requirements.

The system can be transported using different carrier vehicles used by the Bundeswehr. It can be set up at a longitudinal and transverse inclination. A custom lifting system was developed for this purpose, as no off-the-shelf system could meet the specified requirements.

The Bundeswehr is procuring both protected and unprotected versions of the system. This involves the refurbishment of an existing system. However, the new rescue station replaces a complex tent structure with a highly modular 3:1 container manufactured by Rheinmetall Mobile Systeme GmbH. The new system can be transported and set up in more challenging terrain.

Arbor Arms – TradesMed Modular Assault Pack

Tuesday, August 18th, 2026

New from Arbor Arms is the TradesMed Modular Assault Pack.

Designed to meet the specific needs of several mission sets where organizing and managing a large number of small to medium size tools and equipment is critical to mission success. Examples include Medics, EOD Technicians and Drone Operators just to name a few.

The TradesMed Pack has a 3/4 zipper closure allowing you to fully open “book style” the pack and access all your tools quickly and efficiently.

The modular internal Checkmate and Loop Velcro organization system allows you to choose the internal organizer pouches, elastic loop widgets or Velcro One-Wraps to perfectly organize and secure your mission critical equipment. It has an outside center flat zipper pocket with tie down for small and or sensitive items.

Internally there are front and rear channels that allow for storage of flat items as well as hydration bladders. The top of the bag has 2 drink tube ports and the side carry handles allow you to grab it and displace immediately without having to fully repack the bag if you’re under fire.

Offered in a wide variety of colors and patterns.

arborarmsusa.com/shop/tactical-back-packs/tradesmed-modular-assault-pack

Snakestaff Systems Announces Universal Snakeskin Tourniquet Carrier

Thursday, July 30th, 2026

Snakestaff Systems has announced the release of the Universal Snakeskin, a do-it-all tourniquet carrier designed to provide a versatile mounting solution across a broad range of professional, recreational, industrial, and everyday applications.

Developed for compatibility with both the Snakestaff ETQ™ and ETQ Wide™, the Universal Snakeskin addresses a longstanding challenge: securely mounting a tourniquet where immediate access makes the most sense. While traditional mounting solutions have largely been limited to tactical equipment or purpose-built platforms, many everyday environments—including vehicles, bicycles, motorcycles, heavy equipment, work gear, and recreational equipment—have lacked a practical, secure means of carrying hemorrhage control equipment. The Universal Snakeskin bridges that gap by providing a single carrier that performs equally well on conventional load-bearing equipment and in the diverse environments where rapid access to a tourniquet can be equally important.

The carrier incorporates multiple integrated attachment methods into a compact platform, allowing it to be mounted to backpacks, bicycles, motorcycles, vehicle interiors, heavy equipment, rifle stocks, plate carriers, battle belts, climbing harnesses, and numerous other applications.

“Readiness shouldn’t be dictated by the limitations of your equipment and environment,” said Jefferson Colledge, Chief Executive Officer of Snakestaff Systems. “The Universal Snakeskin changes the conversation. Instead of asking where you can mount your tourniquet, it allows you to decide where you should.

The introduction of the Universal Snakeskin reflects Snakestaff Systems’ continued commitment to developing practical, adaptable medical equipment that expands access to lifesaving interventions without adding unnecessary complexity. The carrier is intended for use by military personnel, law enforcement, first responders, industrial workers, outdoor enthusiasts, and responsibly prepared civilians seeking rapid access to lifesaving medical equipment across a wide variety of environments.

The Universal Snakeskin is available immediately through Snakestaff Systems and its authorized dealer network.

BFG Monday: A Med Kit Is Only Useful If You Can Actually Get to It

Monday, July 6th, 2026

Casualties rarely happen when gear is laid out neatly on a tailgate.

They happen in vehicles, in the dark, in tight spaces, during movement, under stress, and usually when nobody has extra time to sort through equipment. In that moment, the question is not whether a Soldier, law enforcement officer, or first responder has medical gear somewhere on their kit. The question is whether that gear can be found, accessed, and put to work immediately.

That difference matters.

Tourniquets, pressure dressings, chest seals, and other trauma supplies have become standard equipment across military, law enforcement, and emergency response communities. Carrying that equipment is important. But carrying medical gear is not the same as being ready to use it.

A med kit buried behind other equipment, mounted too far back on a belt, trapped under layers of load carriage, or difficult to open with one hand may technically be present. But present is not the same as ready. If the user has to fight the setup before treating the casualty, the gear is already working against the mission.


U.S. Air National Guard photo by Master Sgt. Sarah M. McClanahan

Under stress, fine motor skills deteriorate. Decision-making narrows. Tasks that seem simple during equipment layout become harder when the environment is loud, dark, confined, or chaotic. That is why medical gear placement deserves the same level of thought as the contents of the kit itself.

A tactical med kit should be positioned around real use, not just available space.

Can it be reached with either hand?

Can it be accessed while seated in a vehicle?

Can another team member find and deploy it if the casualty cannot?

Can critical items be identified quickly in limited visibility?

Can the kit be opened without dumping the contents or fighting unnecessary closures?

Those questions matter because medical readiness is not measured by how much gear is carried. It is measured by how quickly the right equipment can be employed when seconds matter.

Most warfighters and armed professionals already carry more than enough. Radios, ammunition, comms gear, breaching tools, protective equipment, sustainment items, and mission-specific equipment all compete for limited real estate on the body. As the loadout becomes more complex, medical gear can get pushed into whatever space is left.

That is where problems begin.

An IFAK or trauma kit should not be an afterthought. It should be treated as mission-essential equipment that has to be reachable, identifiable, and secure without becoming a burden. Belt-mounted medical kits, MOLLE-mounted medical pouches, and carrier-mounted trauma kits all have their place, but the location has to match the user, the mission, and the environment.

A patrol officer working from a vehicle may need a different setup than an infantryman moving under load. A member of a tactical team may need the kit accessible to others. A range instructor or prepared citizen may prioritize a smaller belt-mounted trauma kit that can be reached quickly without adding unnecessary bulk.

The right answer depends on the job.

The better way to think about it is not simply, “Do I have a med kit?” It is, “Where should I carry a med kit so it can actually be reached under stress?”


U.S. Marine Corps photo by Sgt. Jorge Borjas

Blue Force Gear® medical kits were built around that reality. The Micro Trauma Kit NOW!® and Trauma Kit NOW!® are designed to keep trauma supplies organized, protected, and accessible without adding unnecessary bulk. The removable insert keeps the contents together, while the BLIP® pull tab allows the kit to be deployed quickly when fine motor skills are compromised. Belt-mounted and MOLLE-mounted options give users the ability to place the kit where it actually makes sense for the mission, not just wherever there is leftover space.

That is especially important when the person who needs the gear may not be the person using it. In a real emergency, another member of the team may be the one reaching for the kit. If they cannot find it, open it, or identify what is inside quickly, valuable time is lost.

Emergencies do not reward preparation on paper.

They reward action.

And action starts with being able to reach the equipment that matters most.

Medical readiness is more than checking a box on an equipment list. It requires thoughtful placement, reliable access, and consistent training. Teams that evaluate trauma equipment through access, not just inventory, are better positioned to respond when seconds matter.

If the kit cannot be reached with either hand, found by another member of the team, or opened when conditions are less than ideal, the setup needs to be reconsidered.

The best medical gear in the world cannot help if it cannot be reached.

That is the reality Blue Force Gear designs for. The Micro Trauma Kit NOW! and Trauma Kit NOW! are built to cut through those critical seconds of hesitation, keeping life-saving supplies exactly where you need them, organized, visible, and ready when hands begin to shake and fine motor skills start to fade. When stress closes in and time slips away, there is no room to search or fumble. In the moment that matters most, access is not just important. It is everything.

For units seeking to increase survivability and operational performance through reduced load carriage by upgrading to Helium Whisper, contact the Blue Force Gear Military Department or visit BlueForceGear.com.